(1997) Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection,

(1999) Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double blind study,

(2001) Intrapleural urokinase in the management of parapneumonic empyema: a randomized controlled trial,

(2004) Intrapleural streptokinase for empyema and complicated parapneumonic effusions,

(2005) U. K. Controlled trial of intrapleural streptokinase for pleural infection,

(jthoracsurg1951;21) The use of streptokinase streptodornase in the treatment of postpneumonic empyema,

(2004) Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema,

(2000) The in vitro efficacy of Varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema,

(2000) Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus,

(2003) Successful treatment of empyema thoraces with human recombinant deoxyribonuclease,

(2003) Suction versus water seal after thoracoscopy for primary spontaneous pneumothorax: prospective randomized study,

(2004) Results of thoracoscopic pleural abrasion for primary spontaneous pneumothorax,

(2003) Videothoracoscopic bleb excision and pleural abrasion for the treatment of primary spontaneous pneumothorax: long-term results,

(2003) Video-assisted thoracic surgical treatment of initial spontaneous pneumothorax in young patients,

(1997) Treatment of complicated pneumothorax by simple talc pleurodesis under thoracoscopy and local anaesthesia,

(2001) Recurrences following videothoracoscopic treatment of primary spontaneous pneumothorax: the role of redo-videothoracoscopy,

(chest1994;106) Talc pleurodesis for the treatment of pneumothorax and pleural effusion,

(2006) Additional minocycline pleurodesis after thoracoscopic surgery for primary spontaneous pneumothorax,

(2004) Effects of additional minocycline pleurodesis after thoracoscopic procedures for primary spontaneous pneumothorax,

(1997) Video assisted thoracoscopic management of primary spontaneous pneumothorax,

(2001) Management of malignant pleural effusions,

(2002) Multilevel likelihood ratios for identifying exudative pleural effusions,

(amrevrespirdis1988;138184-234) State of the art,

(2000) Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effustions,

The treatment of malignant pleural effusions,

Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo,

(2000) The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions,

Indications for pleurectomy in malignant effusion,

(2003) Dry talc pleurodesis via chest tube,

(1998) Thoracoscopic talc poudrage in malignant pleural effusions effective pleurodesis despite low pleural pH,

(2004) The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusion,

(2000) A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions,

Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis,

(1999) Mitomycin chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to gynecological cancer,

(1997) Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin,

(1999) A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions,

(1999) Adult case of isolated noncompaction of left ventricular myocardium revealed at hospitalization for tuberculous pleuritis,

(oncology1988;45) Intrapleural natural beta interferon in the treatment of malignant pleural effusions,

(2001) Progress report on the palliative therapy of 100 patients with neoplastic effusions by intracavitary low-dose interleukin-2,

(2000) Comparison of the effectiveness of some pleural sclerosing agents used for control of effusions in malignant pleural mesothelioma: a review of 117 cases,

(2005) Randomized phase Ⅲ study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European organisation for research and treatment of cancer lung cancer group and the national cancer institute of Canada,

(2003) Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma,

(2003) Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase Ⅱ study,

(2005) Epirubicin and gemcitabine as first-line treatment in malignant pleural mesothelioma,

(2005) A phase Ⅱ study of pemetrexed and carboplatin as first-line chemotherapy in patients with malignant pleural mesothelioma (MPM),

(2005) Phase Ⅱ trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma,

(2002) Vascular endothelial growth factor: the key mediator in pleural effusion formation,

(1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor,

(2004) Vasoactive mediators (VEGF and TNF-α) in patients with malignant and tuberculous pleural effusions,

(2005) Vascular endothelial growth factor in pleural effusions of different origin,

(2000) Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells,

(2000) Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation,

(2005) Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage,